Healthcare >> CEO Interviews >> September 23, 1998
MICHAEL D. GOLDBERG has served as Chairman, CEO and a director of OnCare
since its inception in 1995. In these positions, he oversees all
aspects of the growing cancer practice management company, whose goal is
to enable oncologists to continuously improve care for their cancer
patients through the use of clinical information systems. Previously,
Mr. Goldberg was President and CEO of Axion, Inc., a cancer focused
healthcare service company he founded in 1987. Prior to his tenure with
Axion, he was a partner at the venture capital firm Sevin Rosen Funds,
where he was responsible for the firm's investments in the biomedical
industry. Prior to his tenure with Sevin Rosen, Mr. Goldberg was
Director of Corporate Development and a member of the Operating
Committee at Cetus Corporation, a biotechnology company. Mr. Goldberg
received a B.A. from Brandeis University and an M.B.A. from the Stanford
Graduate School of Business. He is a member of the executive committee
of the board of trustees of the National Childhood Cancer Foundation
where he serves as chairman of the finance and audit committee. Mr.
Goldberg is a founding member of the board of directors of TechNet, a
bipartisan organization of technology and business leaders whose goal is
to create the framework for a new economy for the benefit of their
employees and the community as a whole. He was a recipient of 'Inc.
Magazine's' 1995 Entrepreneur of the Year Award. Profile
anticipate in your sector of the health care market over the next
several years?
Mr. Goldberg: With the shift toward
